Table 1 Characteristics of patients with or without MHEΩ.

From: Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes

 

With MHEn = 55 (%)

Without MHEn = 35 (%)

Age (years)

44.6 ± 11.9

45.5 ± 11.8

Gender

   Male

29(52.7)

19(54.3)

   Female

26(47.3)

16(45.7)

Ascites

   None

35(63.6)

26(74.3)

   Mild to Moderate

19(34.5)

9(25.7)

   Severe

1(1.8)

0

Concomitant HCCµ

4(7.3)

0

Hemoglobin (g/dl)

10.3 ± 1.6

10.1 ± 1.7

Platelets (x10E9/L)

92.6 ± 34

103.7 ± 38.1

Total Bilirubin (mg/dl)

2.6 ± 0.66

2.5 ± 0.78

Direct Bilirubin (mg/dl)

1.5 ± 0.53

1.4 ± 0.61

Indirect Bilirubin (mg/dl)

1.1 ± 0.44

1.04 ± 0.46

Albumin (g/dl)

2.7 ± 0.32

2.8 ± 0.39

Prothrombin time (sec)

15.4 ± 3.0

15.4 ± 2.5

INR∞

1.4 ± 0.28

1.3 ± 0.25

Creatinine (mg/dl)

1.05 ± 0.22

1.02 ± 0.22

CTPα score

8.5 ± 0.99

8.05 ± 0.83*

MELDβ score

14.4 ± 3.06

13.8 ± 3.1

  1. *p < 0.05.
  2. ΩMHE: Minimal Hepatic Encephalopathy.
  3. µHCC: hepatocellular carcinoma,
  4. ∞INR: International normalization ratio.
  5. αCTP: Child-Turcotte-Pugh,
  6. βMELD: Model for End-Stage Liver Disease.
Back to article page